TD Asset Management
OLMA icon

TD Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

TD Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Sell
106,214
-30,186
-22% -$672K ﹤0.01% 1015
2025
Q4 		$3.41M Buy
+136,400
New +$2.43M ﹤0.01% 867

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

TD Asset Management's OLMA Position: Q1 2026 in Review

TD Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 22% in Q1 2026, selling an estimated $672K and leaving 106,214 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

TD Asset Management first reported a position in OLMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.41M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • TD Asset Management held 106,214 shares of Olema Pharmaceuticals worth $1.58M as of Q1 2026.
  • TD Asset Management sold 30,186 Olema Pharmaceuticals shares in Q1 2026, an estimated $672K.
  • Olema Pharmaceuticals made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #1015 holding.
  • TD Asset Management first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • TD Asset Management's Olema Pharmaceuticals position peaked at $3.41M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.